Joan Montero

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

Levi A Garraway, Kwok-Kin Wong, Neal Rosen, 2012, Cancer discovery.

BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response.

Peter Sorger, John A. Bachman, John A Bachman, 2013, Molecular cell.

Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy

Karen Cichowski, A. Letai, R. Berkowitz, 2015, Cell.

Why do BCL-2 inhibitors work and where should we use them in the clinic?

J. Montero, Joan Montero, Antony Letai, 2017, Cell Death and Differentiation.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.

Dynamic BH3 profiling-poking cancer cells with a stick

A. Letai, J. Montero, Joan Montero, 2016, Molecular & cellular oncology.